DYNLL1 and cancer: Specifically, we built each co-expressed PIN (CePIN) to describe specific cellular network statuses characterizing tumorigenesis, progression (four stages), and anticancer drug responses by integrating the large-scale RNA-Seq data across 8 cancer types from TCGA and the microarray gene expression data from the Genomics of Drug Sensitivity in Cancer (GDSC) database [15, 16].